Reuters logo
BRIEF-Cytrx reports strategic realignment of clinical development team
November 6, 2017 / 2:11 PM / 15 days ago

BRIEF-Cytrx reports strategic realignment of clinical development team

Nov 6 (Reuters) - Cytrx Corp:

* Cytrx announces strategic realignment of clinical development team

* Cytrx - announced ‍strategic realignment of drug development efforts for advancing new drug candidates based on ladr technology platform​

* Cytrx Corp - co’s drug development, manufacturing and regulatory activities will be led by Hurley Consulting Associates​

* Cytrx Corp - ‍is poised to file INDS with FDA for one or more new ladr drug conjugates in 2018​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below